Cargando…

Pre-treatment loss to follow-up among children with multidrug-resistant tuberculosis in South Africa, 2008–2010

Multidrug-resistant (MDR) TB is more difficult to diagnose and treat compared with drug-susceptible TB. Young children are at greater risk of severe TB disease and death when treatment is delayed compared to adults. We sought to describe characteristics of children (<13 years) diagnosed with MDR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, Brittany K., Erasmus, Linda, Ershova, Julia, Smith, Sarah E., Ndjeka, Norbert, Podewils, Laura J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138297/ https://www.ncbi.nlm.nih.gov/pubmed/32255811 http://dx.doi.org/10.1371/journal.pone.0230504

Ejemplares similares

Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008–2010
por: Webb Mazinyo, Ernesha, et al.
Publicado: (2016)

Evaluation of a nurse practitioner-physician task-sharing model for multidrug-resistant tuberculosis in South Africa
por: Farley, Jason E., et al.
Publicado: (2017)

Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study
por: Cox, Helen, et al.
Publicado: (2017)

“I would watch her with awe as she swallowed the first handful”: A qualitative study of pediatric multidrug-resistant tuberculosis experiences in Durban, South Africa
por: Misra, Shriya, et al.
Publicado: (2022)

The Impact of Expanded Testing for Multidrug Resistant Tuberculosis Using Geontype MTBDRplus in South Africa: An Observational Cohort Study
por: Hanrahan, Colleen F., et al.
Publicado: (2012)

Correction: The Impact of Expanded Testing for Multidrug Resistant Tuberculosis Using Geontype MTBDRplus in South Africa: An Observational Cohort Study
por: Hanrahan, Colleen F., et al.
Publicado: (2013)

Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis
por: Pai, Helen, et al.
Publicado: (2022)

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Advances in clinical trial design for development of new TB treatments—Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam
por: Brigden, Grania, et al.
Publicado: (2019)

Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa
por: van der Walt, Martie, et al.
Publicado: (2016)

Tuberculosis testing patterns in South Africa to identify groups that would benefit from increased investigation
por: Shapiro, Anne N., et al.
Publicado: (2023)

Completeness and Reliability of the Republic of South Africa National Tuberculosis (TB) Surveillance System
por: Podewils, Laura Jean, et al.
Publicado: (2015)

Multidrug-Resistant Tuberculosis, Somalia, 2010–2011
por: Sindani, Ireneaus, et al.
Publicado: (2013)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011
por: Günther, Gunar, et al.
Publicado: (2015)

Distribution and Clonality of drug-resistant tuberculosis in South Africa
por: Said, Halima, et al.
Publicado: (2021)

Organisation of care for people receiving drug-resistant tuberculosis treatment in South Africa: a mixed methods study
por: Dickson, Lindy, et al.
Publicado: (2023)

Time to appropriate treatment in patients with multidrug-resistant tuberculosis in South Korea: Are we still in 2010?
por: Jo, Eun-Jung, et al.
Publicado: (2019)

Risk Factors for Acquisition of Drug Resistance during Multidrug-Resistant Tuberculosis Treatment, Arkhangelsk Oblast, Russia, 2005–2010
por: Smith, Sarah E., et al.
Publicado: (2015)

Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
por: Ndjeka, Norbert, et al.
Publicado: (2020)

Impact of community tracer teams on treatment outcomes among tuberculosis patients in South Africa
por: Bronner, Liza E, et al.
Publicado: (2012)

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines
por: Gomez, Gabriela Beatriz, et al.
Publicado: (2021)

Assessing Local Risk of Rifampicin-Resistant Tuberculosis in KwaZulu-Natal, South Africa Using Lot Quality Assurance Sampling
por: Heidebrecht, Christine L., et al.
Publicado: (2016)

Initial loss to follow up of tuberculosis patients in South Africa: perspectives of program managers
por: Mwansa-Kambafwile, Judith R. M., et al.
Publicado: (2020)

Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa
por: Salaam-Dreyer, Zubeida, et al.
Publicado: (2021)

High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010
por: Sanchez-Padilla, Elisabeth, et al.
Publicado: (2012)

Determining the risk-factors for molecular clustering of drug-resistant tuberculosis in South Africa
por: Said, Halima, et al.
Publicado: (2023)

Underreported Threat of Multidrug-Resistant Tuberculosis in Africa
por: Ben Amor, Yanis, et al.
Publicado: (2008)

Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial
por: Madan, Jason J, et al.
Publicado: (2020)

A comparative genome analysis of Rift Valley Fever virus isolates from foci of the disease outbreak in South Africa in 2008-2010
por: Maluleke, Moabi R., et al.
Publicado: (2019)

Chest Radiograph Findings and Time to Culture Conversion in Patients with Multidrug-Resistant Tuberculosis and HIV in Tugela Ferry, South Africa
por: Brust, James C. M., et al.
Publicado: (2013)

Performance of GeneXpert MTB/RIF for Diagnosing Tuberculosis Among Symptomatic Household Contacts of Index Patients in South Africa
por: Velen, Kavindhran, et al.
Publicado: (2021)

Preparing the healthcare workforce in South Africa for short-course rifampicin-resistant TB treatment: inter-professional training and task-sharing considerations
por: Farley, Jason E., et al.
Publicado: (2021)

Running CAST 2008-2010
por: Zioutas, K, et al.
Publicado: (2007)

Programmatically Selected Multidrug-Resistant Strains Drive the Emergence of Extensively Drug-Resistant Tuberculosis in South Africa
por: Müller, Borna, et al.
Publicado: (2013)

Multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa: An overview of patients’ reported knowledge and attitudes
por: Maharaj, Jayneetha, et al.
Publicado: (2016)

Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South Africa
por: Loveday, Marian, et al.
Publicado: (2020)

Multidrug and Extensively Drug-resistant Tuberculosis in Canada 1997–2008: Demographic and Disease Characteristics
por: Minion, Jessica, et al.
Publicado: (2013)

The 30-year cardiovascular risk profile of South Africans with diagnosed diabetes, undiagnosed diabetes, pre-diabetes or normoglycaemia: the Bellville, South Africa pilot study
por: Matsha, Tandi E, et al.
Publicado: (2012)

Underdiagnosis of Foodborne Hepatitis A, the Netherlands, 2008–2010
por: Petrignani, Mariska, et al.
Publicado: (2014)

Treatment Outcomes of Multidrug-Resistant Tuberculosis in Taiwan: Tackling Loss to Follow-up
por: Yu, Ming-Chih, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gucr2afs76ip24r4e807940d7p